Skip to content
All Podcasts – Lifestyle
Author:
Bicara Therapeutics Inc.
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
March 5, 2026
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 5, 2026
←
Previous Page
1
2